# Completeness Review: AILivestockHealthMonitoring

- **Review date:** 2026-07-18
- **Assessment basis:** Static source and configuration inspection only. Dependencies were not installed, and no build, database migration, external integration, or runtime workflow was executed.

## Classification

**Prototype-demo**

## Verdict

This is a clinical/health prototype/demo. Its 92 source files and visible routes/pages demonstrate concepts, but they do not establish durable, integrated, tested execution of the AILivestock Health Monitoring workflow.

## Why it is not complete

- 28 files are explicitly named as gap/backlog surfaces, so page and route counts overstate implemented product capability.
- 20 project-owned files contain direct provider/chat-completion markers; generic model calls are not a substitute for typed domain tools, grounded evidence, deterministic rules, or evaluations.
- 25 files contain mock, sample, placeholder, simulated, or random-data signals, leaving important outcomes disconnected from authoritative systems.
- No explicit schema or migration evidence was found for durable, versioned domain state.
- No recognizable project-owned automated tests were found for the primary workflow.
- No checked-in CI workflow was found to continuously verify builds, tests, migrations, and security checks.
- No environment example/template was found, leaving required configuration and secret boundaries undocumented.

## Needed features

1. Implement the Livestock Health Monitoring care workflow with validated observations, decisions, ownership, follow-up, and clinician-visible uncertainty.
2. Connect authoritative EHR/FHIR, laboratory/imaging, device, pharmacy, scheduling, or payer systems appropriate to the workflow, with consent and failure handling.
3. Validate clinical accuracy, calibration, contraindications, missing-data behavior, bias, and escalation on versioned representative datasets.
4. Require clinician approval, least-privilege access, consent, immutable audit, retention controls, and a clearly documented non-diagnostic boundary.
5. Replace the generated “ai disease risk assessment” gap surface with durable domain state, real integration behavior, explicit failure handling, and acceptance tests.
6. Add contract, integration, authorization, migration, failure-path, and end-to-end tests in CI, plus a documented nondestructive deployment/run path.

## Risks or launch blockers

- Incorrect or unreviewed output can cause patient harm.
- Health data requires strong privacy, access, retention, and audit controls.
- The root launcher can terminate unrelated processes occupying configured ports.
- The root launcher seeds, creates, migrates, or otherwise mutates database state during startup.
- The root launcher installs dependencies at run time, reducing reproducibility and expanding supply-chain risk.

## Evidence inspected

- `backend/package.json` — inspected project-owned structure or implementation evidence.
- `backend/models/index.js` — inspected project-owned structure or implementation evidence.
- `backend/routes/gap-ai-breeding-advisor.js` — inspected project-owned structure or implementation evidence.
- `start.sh` — inspected project-owned structure or implementation evidence.
- `backend/config/database.js` — inspected project-owned structure or implementation evidence.
- `backend/middleware/auth.js` — inspected project-owned structure or implementation evidence.

## Recommended next action

Treat this as a prototype: prove one narrow clinical/health outcome end to end with real data, durable state, domain validation, and tests before expanding its feature catalog.

## Implementation progress

**Local status:** The locally actionable governed veterinary-monitoring foundation is implemented. It does not diagnose, prescribe, control devices, connect clinical providers, establish field accuracy, or replace a licensed veterinarian.

- **Needed feature 1 — implemented locally:** `backend/governance/domain.js`, router, and migration persist consented animal/herd identity, unit/source-versioned observations, calibration, advisory decisions with veterinarian owner and visible uncertainty, escalation, follow-up, approval, retirement, export, and erasure.
- **Needed feature 2 — bounded, externally blocked:** veterinary-record, lab/imaging, device, pharmacy, scheduling, and notification work is approval-gated through canonical-idempotent outbox records with checkpoints, retries/dead letters, and receipts. Real integrations require contracts, credentials, mappings, consent, calibrated hardware, and safe environments.
- **Needed feature 3 — implemented locally; clinical/field proof blocked:** versioned validation requires calibration error, false-negative rate, bias strata, contraindication, missing-data, and escalation cases; validators reject invalid units/sources, uncalibrated devices, unsupported evidence, and unsafe medication metadata.
- **Needed feature 4 — implemented locally:** active owner consent, tenant/RBAC isolation, independent veterinarian/health-officer approval, non-diagnostic/autonomous-treatment rejection, immutable audit, scoped export, explicit uncertainty, retention/receipt-backed deletion, and credential rejection form the local boundary.
- **Needed feature 5 — implemented locally:** the generated disease-risk endpoint is unmounted; durable observations, model/evidence versions, uncertainty, veterinarian ownership, follow-up, integration failure state, and acceptance fixtures replace it. Diagnosis/treatment remains blocked.
- **Needed feature 6 — implemented locally:** dependency-free contract/domain/auth/migration/integration/failure/lifecycle tests, CI, tracked config, operations docs, explicit migration, seed quarantine, and non-destructive startup are present.
- **Risk closure:** hard-coded credentials, weak auth, implicit startup schema mutation, runtime install/seed, port killing, and default gap mounts were removed or fail closed.
